HUNTSVILLE, AL – CFD Research Corporation (CFD) announced the formation of Kalm Therapeutics (Kalm Tx) this week to bring a much-needed non-steroidal eczema treatment to patients with mild to moderate atopic dermatitis. The condition affects more than 16 million people in the United States. “After several years of research and development, it is rewarding to […]